为癌症治疗而设计的低氧反应性蛋白纳米颗粒,调节甲基细胞的调节
Wenyan Wang1, Shun-Yu Yao2, Jingjing Luo1
1School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-Sen University, Shenzhen, China.
Nature communications
|January 11, 2025
概括
这项研究引入了针对低氧瘤的新型纳米粒子. 它们结合了氧化来阻断甲基和一种光敏感剂来诱导氧化应激,从而提高了癌症治疗的疗效.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 缺氧瘤由于其对治疗的耐药性而构成治疗挑战.
- 增强的线粒细胞吸收有助于在低氧条件下促进瘤的存活.
- 向线粒是克服瘤耐药性的潜在策略.
研究的目的:
- 开发一种对缺氧反应的纳米粒子系统,用于治疗缺氧瘤.
- 为了同时提供氧化和针对线粒体的光敏化剂.
- 通过调节线粒细胞衰变来诱导级联氧化应激.
主要方法:
- 合成了用阿佐卡利克斯[4]阿伦修改的超分子蛋白纳米颗粒.
- 纳米粒子同时提供氧化和光敏感剂.
- 使用低氧反应药物释放和激光照射.
主要成果:
- 纳米粒子在低氧瘤细胞中释放了货物,破坏了线粒细胞吸收.
- 氧化chloroquine通过抑制mitophagy增加了氧化应激.
- 光敏剂在照射时产生了反应性氧物种,诱导线粒体损伤和线粒体衰变.
- 结合疗法导致放大氧化应激和瘤细胞死亡.
结论:
- 开发的纳米粒子系统有效地向缺氧瘤.
- 同时提供氧化和光敏剂可诱导协同作用的抗瘤效应.
- 这种方法提供了一种有前途的策略,通过操纵线粒和氧化应激来增强癌症治疗.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Electron Transport Chain: Complex I and II
10.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.9K


